|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
CTG008447055 |
| 003 |
DE-627 |
| 005 |
20230425183404.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
220512s2022 xx |||||o 00| ||und c |
| 035 |
|
|
|a (DE-627)CTG008447055
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)DRKS00027067
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EA1/326/21
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a und
|
| 245 |
1 |
0 |
|a Quantified Health
|b Quantified Health - Quantified Health
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 08-04-2022, Last updated: 2022-11-24
|
| 650 |
|
4 |
|a Medical Condition: Orthopaedics: 1. Patients with specific joint pain, limitations in their movement and/or trouble with their perception.2. Patients with chronic back pain or spine syndroms 3. Patients after a slipped disc with conservative or surgical care4. Patients after implantations of knee or hip endoprosthetics # Oncology: Patients after mammae-CA or other oncological disorder with good general condition = 12 weeks after surgery # Cardiology: Initially patients =18 years with a chronic (systolic and/or diastolic) heart insufficience, a coronar hearth disease or patients with auricular fibrillation (after pulmonary vein isolation) treated with intervention or medicinally
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Recruitment Status: Not yet recruiting
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2022) vom: 14. Nov.
|
| 773 |
1 |
8 |
|g year:2022
|g day:14
|g month:11
|
| 856 |
4 |
0 |
|u http://www.drks.de/DRKS00027067
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2022
|b 14
|c 11
|
Klinische Studie